| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $318.9M | +0.6% |
| Cost of Revenue | $79.7M | -1.6% |
| Gross Profit | $239.1M | +1.3% |
| R&D Expense | $77.2M | -12.2% |
| SG&A Expense | $59.2M | +5.9% |
| Operating Income | -$39.1M | +34.0% |
| Pre-tax Income | -$57.6M | +28.7% |
| Income Tax | $1.8M | +45.4% |
| Net Income | -$59.3M | +27.6% |
| EPS (Basic) | -$1.45 | +31.9% |
| EPS (Diluted) | -$1.45 | +31.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.0M | -5.1% |
| Accounts Receivable | $85.5M | +19.4% |
| Current Assets | $153.6M | +8.4% |
| Total Assets | $235.5M | +9.9% |
| Current Liabilities | $271.2M | +6.4% |
| Long-term Debt | $126.5M | +7.5% |
| Total Liabilities | $421.6M | +7.7% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.9M | +187.6% |
| Capital Expenditures | $10.0M | +5.4% |
| Investing Cash Flow | -$10.0M | -5.4% |
| Financing Cash Flow | -$2.2M | -164.9% |
| Free Cash Flow | -$2.0M | +89.1% |
| -$186.1M |
| -5.0% |